This cross-sectional study assesses formulary coverage, patient cost-sharing, and prior authorization requirements for lower-emission inhalers among patients with asthma or chronic obstructive pulmonary disease across US commercial insurance plans.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | PM 2.5 and Emergency Department Visits for Asthma and COPD | 0 | 13.89 | 28-09-2026 |
| 2 | Do you have private health insurance? | 0 | 10 | 08-06-2026 |
| 3 | GSK presents latest respiratory research to advance patient care at ATS 2026 | 0 | 14.1 | 06-05-2026 |
| 4 | Cardiometabolic Disease Education and Health Services Among Public High Schools | 0 | 5.5 | 25-09-2026 |
| 5 | Polypharmacy and Drug-Drug Interactions Among Older Adults | 0 | 9.48 | 24-09-2026 |
| 6 | Efficacy of Technology-Augmented Behavioral Counseling for Risky Firearm Behaviors | 0 | 10.37 | 28-09-2026 |
| 7 | Smartphone Ownership and Eating Disorder Symptoms in Early Adolescence | 0 | 11.89 | 25-09-2026 |
| 8 | Insurance denials on the rise for prescription medications | 0 | 5.74 | 25-09-2026 |
| 9 | Five factors to consider when choosing a pet insurance policy | 0 | 5.5 | 28-09-2026 |
| 10 | Colorado health insurance prices poised for another big jump in 2027 | 0 | 12.94 | 27-09-2026 |